Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures
- PMID: 14999738
- DOI: 10.1002/jps.10583
Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures
Abstract
The objective of this study was to determine the influence of lactose carrier size on drug dispersion of salmeterol xinafoate (SX) from interactive mixtures. SX dispersion was measured by using the fine particle fractions determined by a twin stage impinger attached to a Rotahaler. The particle size of the lactose carrier in the SX interactive mixtures was varied using a range of commercial inhalation-grade lactoses. In addition, differing size fractions of individual lactose samples were achieved by dry sieving. The dispersion of SX appeared to increase as the particle size of the lactose carrier decreased for the mixtures prepared from different particle size commercial samples of lactose and from different sieve fractions of the same lactose. Fine particles of lactose (<5 microm) associated with the lactose carrier were removed from the carrier surface by a wet decantation process to produce lactose samples with low but similar concentrations of fine lactose particles. The fine particle fractions of SX in mixtures prepared with the decanted lactose decreased significantly (analysis of variance, p < 0.001) and the degree of dispersion became independent of the volume mean diameter of the carriers (analysis of variance, p < 0.05). The dispersion behavior is therefore associated with the presence of fine adhered particles associated with the carriers and the inherent size of the carrier itself has little influence on dispersion.
Copyright 2004 Wiley-Liss, Inc. and the American Pharmacists Association.
Similar articles
-
Role of agglomeration in the dispersion of salmeterol xinafoate from mixtures for inhalation with differing drug to fine lactose ratios.J Pharm Sci. 2008 Aug;97(8):3140-52. doi: 10.1002/jps.21228. J Pharm Sci. 2008. PMID: 18023007
-
Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation.Pharm Res. 2006 Nov;23(11):2556-65. doi: 10.1007/s11095-006-9082-6. Epub 2006 Sep 14. Pharm Res. 2006. PMID: 16972185
-
Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures?Pharm Res. 2004 Mar;21(3):492-9. doi: 10.1023/B:PHAM.0000019304.91412.18. Pharm Res. 2004. PMID: 15070101
-
Solubility prediction of salmeterol xinafoate in water--dioxane mixtures.Int J Pharm. 2001 Mar 23;216(1-2):33-41. doi: 10.1016/s0378-5173(00)00694-3. Int J Pharm. 2001. PMID: 11274804 Review.
-
Characterization of the interactions within fine particle mixtures in highly concentrated suspensions for advanced particle processing.Adv Colloid Interface Sci. 2015 Dec;226(Pt A):37-43. doi: 10.1016/j.cis.2015.07.005. Epub 2015 Jul 30. Adv Colloid Interface Sci. 2015. PMID: 26298173 Review.
Cited by
-
The contribution of different formulation components on the aerosol charge in carrier-based dry powder inhaler systems.Pharm Res. 2010 Jul;27(7):1325-36. doi: 10.1007/s11095-010-0115-9. Epub 2010 Mar 31. Pharm Res. 2010. PMID: 20354768
-
Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies.Daru. 2024 Dec;32(2):761-779. doi: 10.1007/s40199-024-00520-3. Epub 2024 Jun 11. Daru. 2024. PMID: 38861247 Free PMC article. Review.
-
The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations.Pharm Res. 2006 Aug;23(8):1665-74. doi: 10.1007/s11095-006-9012-7. Pharm Res. 2006. PMID: 16845584 Review.
-
Advancements in the Design and Development of Dry Powder Inhalers and Potential Implications for Generic Development.Pharmaceutics. 2022 Nov 17;14(11):2495. doi: 10.3390/pharmaceutics14112495. Pharmaceutics. 2022. PMID: 36432683 Free PMC article. Review.
-
Inhaled antibiotic-loaded polymeric nanoparticles for the management of lower respiratory tract infections.Nanoscale Adv. 2021 May 17;3(14):4005-4018. doi: 10.1039/d1na00205h. eCollection 2021 Jul 13. Nanoscale Adv. 2021. PMID: 36132845 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources